NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | -16.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | +20.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | -75.0% | 300 | -75.0% | 0.00% | -83.3% |
| Q3 2020 | $20,000 | -28.6% | 1,200 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $28,000 | +33.3% | 1,200 | 0.0% | 0.01% | +12.5% |
| Q1 2020 | $21,000 | -19.2% | 1,200 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $26,000 | +18.2% | 1,200 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $22,000 | -48.8% | 1,200 | 0.0% | 0.01% | -46.7% |
| Q2 2019 | $43,000 | +7.5% | 1,200 | 0.0% | 0.02% | 0.0% |
| Q1 2019 | $40,000 | +2.6% | 1,200 | 0.0% | 0.02% | -6.2% |
| Q4 2018 | $39,000 | – | 1,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |